Vimarsana
Biggest News Aggregation in the World

Page 4 - Presection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presection Today - Breaking & Trending Today

Risk for Occult Invasive Disease in Oral Cavity Carcinoma - Vimarsana News

Risk for Occult Invasive Disease in Oral Cavity Carcinoma

Surgical excision was associated with improved survival in patients identified with invasive disease.

To Resect or Not to Resect in Stage III NSCLC - Vimarsana News

To Resect or Not to Resect in Stage III NSCLC

When is stage III NSCLC resectable? Experts attempted to reach a consensus on when to perform surgery.

What Does Not Affect Surgical Outcomes in NSCLC? - Vimarsana News

What Does Not Affect Surgical Outcomes in NSCLC?

AEGEAN is one of the first studies of immune checkpoint inhibitors in the perioperative settings to demonstrate improved EFS and pCR with no effect on surgical outcomes.

Blueprint to Curb Postop Opioids After Pancreatic Resection - Vimarsana News

Blueprint to Curb Postop Opioids After Pancreatic Resection

New data suggest that a post-surgery protocol can reduce inpatient opioid use by 50% and lead to opioid-free discharge following pancreatic cancer surgery.

Treatment for Patients Unsuitable for or Refractory to Consolidation Durvalumab - Vimarsana News

Treatment for Patients Unsuitable for or Refractory to Consolidation Durvalumab

Tina Cascone, MD, Ben Levy, MD, and Sandip Patel, MD, offer insights into the treatment approach in patients with unresectable early-stage NSCLC who are unsuitable for consolidation durvalumab or who progress on consolidation durvalumab.